Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Hormonal dependence and cancer in Systemic Lupus Erythematosus.

Cobo-Ibáñez T, Urruticoechea-Arana A, Rúa-Figueroa I, Martín-Martínez MA, Ovalles-Bonilla JG, Galindo M, Calvo-Alén J, Olivé A, Fernández-Nebro A, Menor-Almagro R, Tomero E, Horcada L, Uriarte-Itzazelaia E, Martínez-Taboada VM, Andreu JL, Boteanu A, Narváez J, Bohorquez C, Montilla C, Santos G, Hernández-Cruz B, Vela P, Salgado E, Freire M, Hernández-Beriain JÁ, Díez-Álvarez E, Expósito L, Fernández-Berrizbeitia O, Velloso-Feijoo ML, Ibáñez-Barceló M, Lozano-Rivas N, Bonilla G, Moreno M, Raya E, Quevedo-Vila VE, Vázquez-Rodríguez TR, Ibáñez-Ruan J, Muñoz-Fernández S, Sánchez-Alonso F, Pego-Reigosa JM.

Arthritis Care Res (Hoboken). 2019 Sep 17. doi: 10.1002/acr.24068. [Epub ahead of print]

PMID:
31529686
2.

Can we validate a clinical score to predict the risk of severe infection in patients with systemic lupus erythematosus? A longitudinal retrospective study in a British Cohort.

Tejera Segura B, Rua-Figueroa I, Pego-Reigosa JM, Del Campo V, Wincup C, Isenberg D, Rahman A.

BMJ Open. 2019 Jun 14;9(6):e028697. doi: 10.1136/bmjopen-2018-028697.

3.

Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus.

Rua Figueroa Í, Erausquin C.

Ann Rheum Dis. 2019 Jun 5. pii: annrheumdis-2019-215778. doi: 10.1136/annrheumdis-2019-215778. [Epub ahead of print] No abstract available.

PMID:
31167760
4.

Antisynthetase antibodies in clinical laboratories: the importance of clinical correlation and indirect immunofluorescence.

Greco M, García de Yébenes MJ, Alarcón I, Brandy-García AM, Rúa-Figueroa Í, Loza E, Carmona L.

Ann Rheum Dis. 2019 Jun 5. pii: annrheumdis-2019-215766. doi: 10.1136/annrheumdis-2019-215766. [Epub ahead of print] No abstract available.

PMID:
31167759
5.

Bacteremia in Systemic Lupus Erythematosus in Patients from a Spanish Registry: Risk Factors, Clinical and Microbiological Characteristics, and Outcomes.

Rúa-Figueroa I, López-Longo FJ, Del Campo V, Galindo-Izquierdo M, Uriarte E, Torre-Cisneros J, Vela P, Tomero E, Narváez J, Olivé A, Freire M, Salgado E, Andreu JL, Martínez-Taboada V, Calvo-Alén J, Hernández-Cruz B, Raya E, Quevedo V, Expósito Pérez L, Fernández-Nebro A, Ibañez M, Pascual-Valls È, Rúa-Figueroa D, Naranjo A, Pego-Reigosa JM.

J Rheumatol. 2019 Apr 15. pii: jrheum.180882. doi: 10.3899/jrheum.180882. [Epub ahead of print]

PMID:
30988123
6.

Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria.

Greco M, García de Yébenes MJ, Alarcón I, Brandy-García AM, Rúa-Figueroa Í, Loza E, Carmona L.

Ann Rheum Dis. 2019 Sep;78(9):1291-1292. doi: 10.1136/annrheumdis-2019-215031. Epub 2019 Mar 25. No abstract available.

PMID:
30910990
7.

SER recommendations on the use of biological drugs in primary Sjögren's syndrome.

Andréu Sánchez JL, Fernández Castro M, Del Campo Fontecha PD, Corominas H, Narváez García FJ, Gómez de Salazar JR, Rua-Figueroa Í, Abad Hernández MÁ, Álvarez Rivas MN, Montes JDP, Francisco Hernández FM, Gantes Pedraza MÁ, Greco Merino MG, Hernández MV, Navarro Compán MV, Solarte JAP, Romero Bueno FI, Park HS, Sivera Mascaró F.

Reumatol Clin. 2019 Jan 23. pii: S1699-258X(18)30260-2. doi: 10.1016/j.reuma.2018.10.014. [Epub ahead of print] English, Spanish.

8.

Disease Damage Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Systemic Lupus Erythematosus.

Quevedo-Abeledo JC, Rúa-Figueroa Í, Sánchez-Pérez H, Tejera-Segura B, de Vera-González A, González-Delgado A, Llorca J, González-Gay MÁ, Ferraz-Amaro I.

J Rheumatol. 2019 May;46(5):483-491. doi: 10.3899/jrheum.180881. Epub 2019 Jan 15.

PMID:
30647175
9.

Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort.

Narváez J, Borrell H, Sánchez-Alonso F, Rúa-Figueroa I, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Fernández-Nebro A, Olivé A, Andreu JL, Martínez-Taboada V, Nolla JM, Pego-Reigosa JM; RELESSER Study Group.

Arthritis Res Ther. 2018 Dec 19;20(1):280. doi: 10.1186/s13075-018-1776-8.

10.

Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER).

Torrente-Segarra V, Salman Monte TC, Rúa-Figueroa I, De Uña-Álvarez J, Balboa-Barreiro V, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Mouriño-Rodríguez C, Horcada L, Sánchez-Atrio A, Montilla C, Salgado E, Díez-Álvarez E, Blanco R, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JA, Gantes M, Hernández-Cruz B, Pecondón-Español A, Marras C, Bonilla G, Pego-Reigosa JM; RELESSER Study Group of the Spanish Society of Rheumatology (SER) and the Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER).

Semin Arthritis Rheum. 2019 Jun;48(6):1025-1029. doi: 10.1016/j.semarthrit.2018.09.005. Epub 2018 Sep 27.

PMID:
30344081
11.

Correction to: Musculoskeletal infections caused by Aerococcus urinae: a case-based review.

Greco M, Rúa-Figueroa Í, Ghiglione S, Santana Medina E, Quevedo Abeledo JC, Rodríguez-Lozano C.

Clin Rheumatol. 2018 Sep;37(9):2595-2597. doi: 10.1007/s10067-018-4098-y.

PMID:
29691770
12.

Musculoskeletal infections caused by Aerococcus urinae: a case-based review.

Greco M, Rúa-Figueroa Í, Ghiglione S, Santana Medina E, Quevedo Abeledo JC, Rodríguez-Lozano C.

Clin Rheumatol. 2018 Sep;37(9):2587-2594. doi: 10.1007/s10067-018-4072-8. Epub 2018 Mar 25. Erratum in: Clin Rheumatol. 2018 Apr 19;:.

PMID:
29574655
13.

Transancestral mapping and genetic load in systemic lupus erythematosus.

Langefeld CD, Ainsworth HC, Cunninghame Graham DS, Kelly JA, Comeau ME, Marion MC, Howard TD, Ramos PS, Croker JA, Morris DL, Sandling JK, Almlöf JC, Acevedo-Vásquez EM, Alarcón GS, Babini AM, Baca V, Bengtsson AA, Berbotto GA, Bijl M, Brown EE, Brunner HI, Cardiel MH, Catoggio L, Cervera R, Cucho-Venegas JM, Dahlqvist SR, D'Alfonso S, Da Silva BM, de la Rúa Figueroa I, Doria A, Edberg JC, Endreffy E, Esquivel-Valerio JA, Fortin PR, Freedman BI, Frostegård J, García MA, de la Torre IG, Gilkeson GS, Gladman DD, Gunnarsson I, Guthridge JM, Huggins JL, James JA, Kallenberg CGM, Kamen DL, Karp DR, Kaufman KM, Kottyan LC, Kovács L, Laustrup H, Lauwerys BR, Li QZ, Maradiaga-Ceceña MA, Martín J, McCune JM, McWilliams DR, Merrill JT, Miranda P, Moctezuma JF, Nath SK, Niewold TB, Orozco L, Ortego-Centeno N, Petri M, Pineau CA, Pons-Estel BA, Pope J, Raj P, Ramsey-Goldman R, Reveille JD, Russell LP, Sabio JM, Aguilar-Salinas CA, Scherbarth HR, Scorza R, Seldin MF, Sjöwall C, Svenungsson E, Thompson SD, Toloza SMA, Truedsson L, Tusié-Luna T, Vasconcelos C, Vilá LM, Wallace DJ, Weisman MH, Wither JE, Bhangale T, Oksenberg JR, Rioux JD, Gregersen PK, Syvänen AC, Rönnblom L, Criswell LA, Jacob CO, Sivils KL, Tsao BP, Schanberg LE, Behrens TW, Silverman ED, Alarcón-Riquelme ME, Kimberly RP, Harley JB, Wakeland EK, Graham RR, Gaffney PM, Vyse TJ.

Nat Commun. 2017 Jul 17;8:16021. doi: 10.1038/ncomms16021.

14.

Juvenile- and adult-onset systemic lupus erythematosus: a comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER).

Torrente-Segarra V, Salman Monte TC, Rúa-Figueroa I, Sánchez-Alonso F, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Ibañez-Ruán J, Horcada L, Sánchez-Atrio A, Montilla C, Melero González RB, Díez-Álvarez E, Martinez-Taboada V, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JÁ, Gantes M, Hernández-Cruz B, Pecondón-Español Á, Marras C, Bonilla G, Pego-Reigosa JM; RELESSER Study Group of the Spanish Society of Rheumatology (SER) and the Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER).

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):1047-1055. Epub 2017 Jun 12.

PMID:
28628467
15.

Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature.

Silva-Fernández L, Otón T, Askanase A, Carreira P, López-Longo FJ, Olivé A, Rúa-Figueroa Í, Narváez J, Ruiz-Lucea E, Andrés M, Calvo E, Toyos F, Alegre-Sancho JJ, Tomero E, Montilla C, Zea A, Uriarte E, Calvo-Alén J, Marras C, Martínez-Taboada VM, Belmonte-López MÁ, Rosas J, Raya E, Bonilla G, Freire M, Pego-Reigosa JM, Millán I, Hughes-Morley A, Andreu JL; from the Spanish Society for Rheumatology Systemic Autoimmune Diseases Study Group (EAS-SER).

Reumatol Clin. 2019 Jan - Feb;15(1):34-42. doi: 10.1016/j.reuma.2017.04.005. Epub 2017 May 18. English, Spanish.

16.

Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus.

Rúa-Figueroa Í, López-Longo J, Galindo-Izquierdo M, Calvo-Alén J, Del Campo V, Olivé-Marqués A, Pérez-Vicente S, Fernández-Nebro A, Andrés M, Erausquin C, Tomero E, Horcada L, Uriarte E, Freire M, Montilla C, Sánchez-Atrio A, Santos G, Boteanu A, Díez-Álvarez E, Narváez J, Martínez-Taboada V, Silva-Fernández L, Ruiz-Lucea E, Andreu JL, Hernández-Beriain JÁ, Gantes M, Hernández-Cruz B, Pérez-Venegas J, Pecondón-Español Á, Marras C, Ibáñez-Barceló M, Bonilla G, Torrente V, Castellví I, Alegre JJ, Calvet J, Marenco JL, Raya E, Vázquez T, Quevedo V, Muñoz-Fernández S, Rodríguez-Gómez M, Ibáñez J, Pego-Reigosa JM.

Semin Arthritis Rheum. 2017 Aug;47(1):38-45. doi: 10.1016/j.semarthrit.2017.01.010. Epub 2017 Jan 27.

PMID:
28259425
17.

Systemic lupus erythematosus in Spanish males: a study of the Spanish Rheumatology Society Lupus Registry (RELESSER) cohort.

Riveros Frutos A, Casas I, Rúa-Figueroa I, López-Longo FJ, Calvo-Alén J, Galindo M, Fernández-Nebro A, Pego-Reigosa JM, Olivé Marqués A; RELESSER Group, part of the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER).

Lupus. 2017 Jun;26(7):698-706. doi: 10.1177/0961203316673728. Epub 2016 Oct 31.

PMID:
27799439
18.

Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study.

Rúa-Figueroa I, Fernández Castro M, Andreu JL, Sanchez-Piedra C, Martínez-Taboada V, Olivé A, López-Longo J, Rosas J, Galindo M, Calvo-Alén J, Fernández-Nebro A, Alonso F, Rodríguez-Lozano B, Alberto García Vadillo J, Menor R, Narváez FJ, Erausquin C, García-Aparicio Á, Tomero E, Manrique-Arija S, Horcada L, Uriarte E, Gil S, Blanco R, López-González R, Boteanu A, Freire M, Galisteo C, Rodríguez-Gómez M, Díez-Álvarez E, Pego-Reigosa JM; Sjogrenser and Relesser Researchers and EAS-SER Group.

Arthritis Care Res (Hoboken). 2017 Jan;69(1):38-45. doi: 10.1002/acr.23015. Epub 2016 Nov 21.

19.

Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry.

Pego-Reigosa JM, Lois-Iglesias A, Rúa-Figueroa Í, Galindo M, Calvo-Alén J, de Uña-Álvarez J, Balboa-Barreiro V, Ibáñez Ruan J, Olivé A, Rodríguez-Gómez M, Fernández Nebro A, Andrés M, Erausquin C, Tomero E, Horcada Rubio L, Uriarte Isacelaya E, Freire M, Montilla C, Sánchez-Atrio AI, Santos-Soler G, Zea A, Díez E, Narváez J, Blanco-Alonso R, Silva-Fernández L, Ruiz-Lucea ME, Fernández-Castro M, Hernández-Beriain JÁ, Gantes-Mora M, Hernández-Cruz B, Pérez-Venegas J, Pecondón-Español Á, Marras Fernández-Cid C, Ibáñez-Barcelo M, Bonilla G, Torrente-Segarra V, Castellví I, Alegre JJ, Calvet J, Marenco de la Fuente JL, Raya E, Vázquez-Rodríguez TR, Quevedo-Vila V, Muñoz-Fernández S, Otón T, Rahman A, López-Longo FJ.

Rheumatology (Oxford). 2016 Jul;55(7):1243-50. doi: 10.1093/rheumatology/kew049. Epub 2016 Mar 27.

PMID:
27018057
20.

Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER).

Galindo-Izquierdo M, Rodriguez-Almaraz E, Pego-Reigosa JM, López-Longo FJ, Calvo-Alén J, Olivé A, Fernández-Nebro A, Martinez-Taboada V, Vela-Casasempere P, Freire M, Narváez FJ, Rosas J, Ibáñez-Barceló M, Uriarte E, Tomero E, Zea A, Horcada L, Torrente V, Castellvi I, Calvet J, Menor-Almagro R, Zamorano MA, Raya E, Díez-Álvarez E, Vázquez-Rodríguez T, García de la Peña P, Movasat A, Andreu JL, Richi P, Marras C, Montilla-Morales C, Hernández-Cruz B, Marenco de la Fuente JL, Gantes M, Úcar E, Alegre-Sancho JJ, Manero J, Ibáñez-Ruán J, Rodríguez-Gómez M, Quevedo V, Hernández-Beriaín J, Silva-Fernández L, Alonso F, Pérez S, Rúa-Figueroa I; RELESSER Group, from Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER).

Medicine (Baltimore). 2016 Mar;95(9):e2891. doi: 10.1097/MD.0000000000002891.

21.

Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: Prevalence and Predictors.

Pérez-Peñate GM, Rúa-Figueroa I, Juliá-Serdá G, León-Marrero F, García-Quintana A, Ortega-Trujillo JR, Erausquin-Arruabarrena C, Rodríguez-Lozano C, Cabrera-Navarro P, Ojeda-Betancor N, Gómez-Sánchez MÁ.

J Rheumatol. 2016 Feb;43(2):323-9. doi: 10.3899/jrheum.150451. Epub 2015 Dec 15.

PMID:
26669915
22.

Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus.

Torrente-Segarra V, Salman-Monte TC, Rúa-Figueroa Í, Pérez-Vicente S, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Ibañez-Ruán J, Horcada L, Sánchez-Atrio A, Montilla C, Rodríguez-Gómez M, Díez-Álvarez E, Martinez-Taboada V, Andreu JL, Fernández-Berrizbeitia O, Hernández-Beriain JA, Gantes M, Hernández-Cruz B, Pecondón-Español Á, Marras C, Bonilla G, Pego-Reigosa JM; RELESSER Study Group of the Spanish Society of Rheumatology (SER); Study Group of Systemic Autoimmune Diseases of the SER (EAS-SER).

Clin Exp Rheumatol. 2016 Mar-Apr;34(2 Suppl 96):S40-7. Epub 2015 Nov 17.

PMID:
26575317
23.

Healthy lifestyle habits for patients with systemic lupus erythematosus: A systemic review.

Rodríguez Huerta MD, Trujillo-Martín MM, Rúa-Figueroa Í, Cuellar-Pompa L, Quirós-López R, Serrano-Aguilar P; Spanish SLE CPG Development Group.

Semin Arthritis Rheum. 2016 Feb;45(4):463-70. doi: 10.1016/j.semarthrit.2015.09.003. Epub 2015 Oct 1. Review.

PMID:
26522137
24.

Cardiovascular Events in Systemic Lupus Erythematosus: A Nationwide Study in Spain From the RELESSER Registry.

Fernández-Nebro A, Rúa-Figueroa Í, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, Ordóñez-Cañizares C, Martín-Martínez MA, Blanco R, Melero-González R, Ibáñez-Rúan J, Bernal-Vidal JA, Tomero-Muriel E, Uriarte-Isacelaya E, Horcada-Rubio L, Freire-González M, Narváez J, Boteanu AL, Santos-Soler G, Andreu JL, Pego-Reigosa JM; EAS-SER (Systemic Diseases Study Group of Spanish Society of Rheumatology).

Medicine (Baltimore). 2015 Jul;94(29):e1183. doi: 10.1097/MD.0000000000001183.

25.

Efficacy of Raynaud's phenomenon and digital ulcer pharmacological treatment in systemic sclerosis patients: a systematic literature review.

García de la Peña Lefebvre P, Nishishinya MB, Pereda CA, Loza E, Sifuentes Giraldo WA, Román Ivorra JA, Carreira P, Rúa-Figueroa I, Pego-Reigosa JM, Muñoz-Fernández S.

Rheumatol Int. 2015 Sep;35(9):1447-59. doi: 10.1007/s00296-015-3241-1. Epub 2015 Apr 1. Review.

PMID:
25824427
26.

Classification of Systemic Lupus Erythematosus: Systemic Lupus International Collaborating Clinics Versus American College of Rheumatology Criteria. A Comparative Study of 2,055 Patients From a Real-Life, International Systemic Lupus Erythematosus Cohort.

Inês L, Silva C, Galindo M, López-Longo FJ, Terroso G, Romão VC, Rúa-Figueroa I, Santos MJ, Pego-Reigosa JM, Nero P, Cerqueira M, Duarte C, Miranda LC, Bernardes M, Gonçalves MJ, Mouriño-Rodriguez C, Araújo F, Raposo A, Barcelos A, Couto M, Abreu P, Otón-Sanchez T, Macieira C, Ramos F, Branco JC, Silva JA, Canhão H, Calvo-Alén J; Rheumatic Diseases Registry of the Portuguese Society of Rheumatology; Registry of Systemic Lupus Erythematosus Patients of the Spanish Society of Rheumatology.

Arthritis Care Res (Hoboken). 2015 Aug;67(8):1180-5. doi: 10.1002/acr.22539.

27.

Comprehensive description of clinical characteristics of a large systemic lupus erythematosus cohort from the Spanish Rheumatology Society Lupus Registry (RELESSER) with emphasis on complete versus incomplete lupus differences.

Rúa-Figueroa Í, Richi P, López-Longo FJ, Galindo M, Calvo-Alén J, Olivé-Marqués A, Loza-Santamaría E, Vicente SP, Erausquin C, Tomero E, Horcada L, Uriarte E, Sánchez-Atrio A, Rosas J, Montilla C, Fernández-Nebro A, Rodríguez-Gómez M, Vela P, Blanco R, Freire M, Silva L, Díez-Álvarez E, Ibáñez-Barceló M, Zea A, Narváez J, Martínez-Taboada V, Marenco JL, de Castro MF, Fernández-Berrizbeitia O, Hernández-Beriain JÁ, Gantes M, Hernández-Cruz B, Pérez-Venegas JJ, Pecondón Á, Marras C, Carreira P, Bonilla G, Torrente V, Castellví I, Alegre J, Moreno M, Raya E, de la Peña PG, Vázquez T, Aguirre Á, Quevedo V, Pego-Reigosa JM; EAS-SER (Systemic Diseases Study Group of the Spanish Society of Rheumatology).

Medicine (Baltimore). 2015 Jan;94(1):e267. doi: 10.1097/MD.0000000000000267.

28.

Analysis of disease activity and response to treatment in a large Spanish cohort of patients with systemic lupus erythematosus.

Pego-Reigosa JM, Rúa-Figueroa Í, López-Longo FJ, Galindo-Izquierdo M, Calvo-Alén J, Olivé-Marqués A, del Campo V, García-Yébenes MJ, Loza-Santamaría E, Blanco R, Melero-González R, Vela-Casasempere P, Otón-Sánchez T, Tomero-Muriel E, Uriarte-Isacelaya E, Fito-Manteca MC, Freire-González M, Narváez J, Fernández-Nebro A, Zea-Mendoza A, Rosas J; RELESSER Group, from the Spanish Society of Rheumatology Systemic Autoimmune Diseases Study Group (EASSER).

Lupus. 2015 Jun;24(7):720-9. doi: 10.1177/0961203314563818. Epub 2014 Dec 15. Erratum in: Lupus. 2015 Aug;24(9):1008. Carlos Rosas, J [corrected to Rosas, J].

PMID:
25516473
29.

Clinical and immunogenetic factors associated with pneumonia in patients with systemic lupus erythematosus: a case-control study.

Rúa-Figueroa I, Nóvoa J, García-Laorden MI, Erausquin C, García-Bello M, Rodríguez de Castro F, Herrera-Ramos E, Ojeda S, Quevedo JC, Francisco F, Naranjo A, Rodríguez-Lozano C, Rodríguez-Gallego C.

J Rheumatol. 2014 Sep;41(9):1801-7. doi: 10.3899/jrheum.131470. Epub 2014 Aug 1.

PMID:
25086072
30.

Clinical composite measures of disease activity and damage used to evaluate patients with systemic lupus erythematosus: A systematic literature review.

Castrejón I, Rúa-Figueroa I, Rosario MP, Carmona L.

Reumatol Clin. 2014 Sep-Oct;10(5):309-20. doi: 10.1016/j.reuma.2014.01.012. Epub 2014 Jul 10. Review.

31.

Identification of lymphoma predictors in patients with primary Sjögren's syndrome: a systematic literature review and meta-analysis.

Nishishinya MB, Pereda CA, Muñoz-Fernández S, Pego-Reigosa JM, Rúa-Figueroa I, Andreu JL, Fernández-Castro M, Rosas J, Loza Santamaría E.

Rheumatol Int. 2015 Jan;35(1):17-26. doi: 10.1007/s00296-014-3051-x. Epub 2014 Jun 5. Review.

PMID:
24899571
32.

The effects of rituximab on the lipid profile of patients with active systemic lupus erythematosus: results from a nationwide cohort in Spain (LESIMAB).

Fernández-Nebro A, Marenco JL, López-Longo F, Galindo M, Hernández-Cruz BE, Narváez J, Rúa-Figueroa I, Raya-Alvarez E, Zea A, Freire M, Sánchez-Atrio AI, García-Vicuña R, Pego-Reigosa JM, Manrique-Arija S, Nieves-Martín L, Carreño L; LESIMAB GROUP.

Lupus. 2014 Sep;23(10):1014-22. doi: 10.1177/0961203314534909. Epub 2014 May 15.

PMID:
24833667
33.

Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: a systematic review.

Cobo-Ibáñez T, Loza-Santamaría E, Pego-Reigosa JM, Marqués AO, Rúa-Figueroa I, Fernández-Nebro A, Cáliz Cáliz R, López Longo FJ, Muñoz-Fernández S.

Semin Arthritis Rheum. 2014 Oct;44(2):175-85. doi: 10.1016/j.semarthrit.2014.04.002. Epub 2014 Apr 13. Review.

PMID:
24830791
34.

Results of a specific smoking cessation program for patients with arthritis in a rheumatology clinic.

Naranjo A, Bilbao A, Erausquin C, Ojeda S, Francisco FM, Rúa-Figueroa I, Rodríguez-Lozano C.

Rheumatol Int. 2014 Jan;34(1):93-9. doi: 10.1007/s00296-013-2851-8. Epub 2013 Sep 5.

PMID:
24005567
35.

Biological therapy for systemic vasculitis: a systematic review.

Silva-Fernández L, Loza E, Martínez-Taboada VM, Blanco R, Rúa-Figueroa I, Pego-Reigosa JM, Muñoz-Fernández S; Systemic Autoimmune Diseases Study Group of the Spanish Society for Rheumatology (EAS-SER).

Semin Arthritis Rheum. 2014 Feb;43(4):542-57. doi: 10.1016/j.semarthrit.2013.07.010. Epub 2013 Aug 24. Review.

PMID:
23978781
36.

SER consensus statement on the use of biologic therapy for systemic lupus erythematosus.

Calvo-Alén J, Silva-Fernández L, Úcar-Angulo E, Pego-Reigosa JM, Olivé A, Martínez-Fernández C, Martínez-Taboada V, Luis Marenco J, Loza E, López-Longo J, Gómez-Reino JJ, Galindo-Izquierdo M, Fernández-Nebro A, Cuadrado MJ, Aguirre-Zamorano MÁ, Zea-Mendoza A, Rúa-Figueroa I; Sociedad Española de Reumatología.

Reumatol Clin. 2013 Sep-Oct;9(5):281-96. doi: 10.1016/j.reuma.2013.04.001. Epub 2013 Jul 17. English, Spanish.

37.

National registry of patients with systemic lupus erythematosus of the Spanish Society of Rheumatology: objectives and methodology.

Rúa-Figueroa I, López-Longo FJ, Calvo-Alén J, Galindo-Izquierdo M, Loza E, García de Yebenes MJ, Pego-Reigosa JM; Grupo de trabajo en Enfermedades Autoinmunes Sistémicas de la Sociedad Española de Reumatología (EAS-SER); Unidad de Investigación de la Sociedad Española de Reumatología (UI-SER).

Reumatol Clin. 2014 Jan-Feb;10(1):17-24. doi: 10.1016/j.reuma.2013.04.013. Epub 2013 Jul 17. English, Spanish.

38.

Efficacy and safety of nonbiologic immunosuppressants in the treatment of nonrenal systemic lupus erythematosus: a systematic review.

Pego-Reigosa JM, Cobo-Ibáñez T, Calvo-Alén J, Loza-Santamaría E, Rahman A, Muñoz-Fernández S, Rúa-Figueroa Í.

Arthritis Care Res (Hoboken). 2013 Nov;65(11):1775-85. Review.

39.

Direct cost of management and treatment of active systemic lupus erythematosus and its flares in Spain: the LUCIE Study.

Cervera R, Rúa-Figueroa I, Gil-Aguado A, Sabio JM, Pallarés L, Hernández-Pastor LJ, Iglesias M.

Rev Clin Esp (Barc). 2013 Apr;213(3):127-37. doi: 10.1016/j.rce.2012.11.018. Epub 2013 Feb 8. English, Spanish.

PMID:
23398815
40.

Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study.

Fernández-Nebro A, de la Fuente JL, Carreño L, Izquierdo MG, Tomero E, Rúa-Figueroa I, Hernández-Cruz BE, Narváez J, Ucar E, Olivé A, Zea A, Fernández-Castro M, Raya-Álvarez E, Pego-Reigosa JM, Freire M, Martínez-Taboada VM, Pérez-Venegas J, Sánchez-Atrio AI, Villa-Blanco I, Manrique-Arija S, López-Longo FJ, Carreira PE, Martínez-Pérez R, García-Vicuña R.

Lupus. 2012 Sep;21(10):1063-76. doi: 10.1177/0961203312446627. Epub 2012 Jul 11.

PMID:
22786985
41.

[Application of guidelines for secondary prevention of fracture and the FRAX index in patients with fragility fracture].

Naranjo A, Ojeda-Bruno S, Francisco-Hernández F, Erausquin C, Rúa-Figueroa I, Rodríguez-Lozano C.

Med Clin (Barc). 2011 Mar 19;136(7):290-2. doi: 10.1016/j.medcli.2010.06.028. Epub 2010 Dec 24. Spanish.

PMID:
21185575
42.

Secondary prevention program for osteoporotic fractures and long-term adherence to bisphosphonates.

Ojeda-Bruno S, Naranjo A, Francisco-Hernández F, Erausquin C, Rúa-Figueroa I, Quevedo JC, Rodríguez-Lozano C.

Osteoporos Int. 2011 Jun;22(6):1821-8. doi: 10.1007/s00198-010-1414-z. Epub 2010 Oct 6.

PMID:
20924747
43.

Limited value of ultrasound assessment in patients with poor outcome after carpal tunnel release surgery.

Naranjo A, Ojeda S, Rúa-Figueroa I, Garcia-Duque O, Fernández-Palacios J, Carmona L.

Scand J Rheumatol. 2010;39(5):409-12. doi: 10.3109/03009741003685632.

PMID:
20560809
44.

Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study.

Rua-Figueroa I, Arencibia-Mireles O, Elvira M, Erausquin C, Ojeda S, Francisco F, Naranjo A, Rodríguez-Gallego C, Garcia-Laorden I, Rodríguez-Perez J, Rodríguez-Lozano C.

Ann Rheum Dis. 2010 Jun;69(6):1136-9. doi: 10.1136/ard.2008.104349. Epub 2009 Aug 16.

PMID:
19687018
45.

Interleukin-10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands.

Rosado S, Rua-Figueroa I, Vargas JA, Garcia-Laorden MI, Losada-Fernandez I, Martin-Donaire T, Perez-Chacon G, Rodriguez-Gallego C, Naranjo-Hernandez A, Ojeda-Bruno S, Citores MJ, Perez-Aciego P.

Int J Immunogenet. 2008 Jun;35(3):235-42. doi: 10.1111/j.1744-313X.2008.00762.x. Epub 2008 Apr 7.

PMID:
18397303
46.

Association of the microsatellite in the 3' untranslated region of the CD154 gene with rheumatoid arthritis in females from a Spanish cohort: a case-control study.

Martin-Donaire T, Losada-Fernandez I, Perez-Chacon G, Rua-Figueroa I, Erausquin C, Naranjo-Hernandez A, Rosado S, Sanchez F, Garcia-Saavedra A, Citores MJ, Vargas JA, Perez-Aciego P.

Arthritis Res Ther. 2007;9(5):R89.

47.

Paraneoplastic pemphigus associated with Castleman's disease: usefulness of the laboratory of autoimmunity in the diagnosis of this disease.

Alarcón-Torres I, Bastida-Iñarrea J, Rodríguez-Salido MJ, Gómez-Duaso J, Rua-Figueroa I, García-Aguilar GD, Martín-Alfaro R.

Ann N Y Acad Sci. 2007 Jun;1107:231-8.

PMID:
17804551
48.

The dinucleotide repeat polymorphism in the 3'UTR of the CD154 gene has a functional role on protein expression and is associated with systemic lupus erythematosus.

Citores MJ, Rua-Figueroa I, Rodriguez-Gallego C, Durántez A, García-Laorden MI, Rodríguez-Lozano C, Rodríguez-Pérez JC, Vargas JA, Pérez-Aciego P.

Ann Rheum Dis. 2004 Mar;63(3):310-7.

49.

Mannose binding lectin polymorphisms as a disease-modulating factor in women with systemic lupus erythematosus from Canary Islands, Spain.

García-Laorden MI, Rúa-Figueroa I, Pérez-Aciego P, Rodríguez-Pérez JC, Citores MJ, Alamo F, Erausquin C, Rodríguez-Gallego C.

J Rheumatol. 2003 Apr;30(4):740-6.

PMID:
12672193
50.

Fibromyalgia in patients with rheumatoid arthritis is associated with higher scores of disability.

Naranjo A, Ojeda S, Francisco F, Erausquin C, Rúa-Figueroa I, Rodríguez-Lozano C.

Ann Rheum Dis. 2002 Jul;61(7):660-1. No abstract available.

Supplemental Content

Loading ...
Support Center